Gene · 4175
Papers2,153
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 2,153
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression and Prognostic Value of MCM Family Genes in Osteosarcoma. | Front Mol Biosci | 2021 | 34239894 | PubTator, text mining | PubMed |
| Upregulating KTN1 promotes Hepatocellular Carcinoma progression. | J Cancer | 2021 | 34234850 | PubTator, text mining | PubMed |
| MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastoma. | BMC Cancer | 2021 | 34233647 | PubTator, text mining | PubMed |
| Overexpression of HPRT1 is associated with poor prognosis in head and neck squamous cell carcinoma. | FEBS Open Bio | 2021 | 34231338 | PubTator, text mining | PubMed |
| Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency. | Mol Cell | 2021 | 34216544 | PubTator, text mining | PubMed |
| How a Paleogenomic Approach Can Provide Details on Bioarchaeological Reconstruction: A Case Study from the Globular Amphorae Culture. | Genes (Basel) | 2021 | 34208224 | PubTator, text mining | PubMed |
| Evaluating the Robustness of Biomarkers of Dairy Food Intake in a Free-Living Population Using Single- and Multi-Marker Approaches. | Metabolites | 2021 | 34204298 | PubTator, text mining | PubMed |
| Reconstitution of human CMG helicase ubiquitylation by CUL2LRR1 and multiple E2 enzymes. | Biochem J | 2021 | 34195792 | PubTator, text mining | PubMed |
| Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis. | Hum Genomics | 2021 | 34187556 | PubTator, text mining | PubMed |
| Causal interactions from proteomic profiles: Molecular data meet pathway knowledge. | Patterns (N Y) | 2021 | 34179843 | PubTator, text mining | PubMed |
| Systemic Analysis of the DNA Replication Regulator MCM Complex in Ovarian Cancer and Its Prognostic Value. | Front Oncol | 2021 | 34178669 | PubTator, text mining | PubMed |
| Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer. | BMC Cancer | 2021 | 34174849 | PubTator, text mining | PubMed |
| MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer. | Sci Rep | 2021 | 34172788 | PubTator, text mining | PubMed |
| ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress. | Nat Commun | 2021 | 34162889 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis reveals disparate effector differentiation pathways in human Treg compartment. | Nat Commun | 2021 | 34162888 | PubTator, text mining | PubMed |
| The γ-tubulin meshwork assists in the recruitment of PCNA to chromatin in mammalian cells. | Commun Biol | 2021 | 34158617 | PubTator, text mining | PubMed |
| Somatic mutation subtypes of lung adenocarcinoma in East Asian reveal divergent biological characteristics and therapeutic vulnerabilities. | iScience | 2021 | 34142036 | PubTator, text mining | PubMed |
| The paeonol target gene autophagy-related 5 has a potential therapeutic value in psoriasis treatment. | PeerJ | 2021 | 34113484 | PubTator, text mining | PubMed |
| Multiomics analysis reveals CT83 is the most specific gene for triple negative breast cancer and its hypomethylation is oncogenic in breast cancer. | Sci Rep | 2021 | 34108519 | PubTator, text mining | PubMed |
| Silencing HIPPI Suppresses Tumor Progression in Non-Small-Cell Lung Cancer by Inhibiting DNA Replication. | Onco Targets Ther | 2021 | 34079292 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4175/papers?page=31